An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive
辉瑞辉瑞(US:PFE) WSJ·2026-03-24 00:46

公司动态 - 公司正在为其新药寻求监管审查 [1] - 该新药是数十年来首款针对该疾病的新疫苗 [1]

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive - Reportify